Trial
On-Going Trials
Disease Site | Trial Name | Trial Number | Trial Description | URL | Contact Person | Trial Status |
Cervix | INTERLACE (Induction Chemotherapy Plus Chemoradiation as First Line Treatment for Locally Advanced Cervical Cancer) |
NCT01566240 | KolGOTrg is recruiting patients from India(SGCCRI and CNCI, Kolkata) in this CCRN/GCIG study sponsored by UCL
Patient Information Sheet for Indian centres: (Download in English) (Download in Bengali) (Download in Hindi) |
http://www.kolgotrg.org/interlace/ | Country PI (India): Asima Mukhopadhyay PI SGCCRI: Rahul Roy Chowdhury PI CNCI: Ranajit Mandal Study coordinator(India): Twinkle Sinha Contact: interlacekolctc@gmail.com |
Recruiting |
Cervix | SENTICOL (International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer) |
NCT03386734 | KolGOTrg is recruiting patients from India(CNCI, Kolkata) in this CCRN/GCIG study sponsored by Centre Hospitalier Universitaire de Besancon Patient Information Sheet for Indian centres: (Download in English) (Download in Bengali) (Download in Hindi) |
http://www.kolgotrg.org/senticol/ | Country PI (India): Asima Mukhopadhyay PI CNCI: Asima Mukhopadhay Study coordinator(India): Mou Dasgupta Contact: kolgotrg@gmail.com |
Recruitment in India pending for CTRI registration |
Ovary | HIPEC-HR (HIPEC in Homologous Recombination Stratified Ovarian cancer) |
KOLGO-PROVAR-001 | KolGOTrg will be starting recruitment shortly in this multicentric international translational proof-of-concept study. Study sponsor: KolGOTrg Funding: DST-UKIERI |
http://www.kolgotrg.org/hipec-hr/ | Study PI: Asima Mukhopadhyay PI CNCI: Asima Mukhopadhyay Ranajit Mandal PI SGCCRI: Rahul Roy Chowdhury PI AIIMS Delhi: Neerja Bhatla Study coordinator: Dona Chakraborty Contact: kolgotrg@gmail.com |
Developmental Phase for the clinical trial. |
Ovary | IPIROC (Intermittent PARP Inhibitor in Recurrent Ovarian Cancer) |
KOLGO-PROVAR-002 | KolGOTrg will be starting recruitment shortly in the IPIROC series of translationa proof-of-concept studies(multicentric, international) Study sponsor: KolGOTrg Funding: 1. CRUK DBT Seed Fund 2. DST-UKIERI |
http://www.kolgotrg.org/ipiroc/ | Study PI: Asima Mukhopadhyay PI CNCI: Asima Mukhopadhyay Ranajit Mandal PI SGCCRI: Rahul Roy Chowdhury Study coordinator: Dona Chakraborty Contact: kolgotrg@gmail.com |
IPIROC-1 (translational study) ongoing Study sites: CNCI Kolkata and Newcastle University, UK |
Ovary | HOTROC (Hormone Therapy in Recurrent Ovarian Cancer) |
KOLGO-PROVAR-003 | KolGOTrg will be starting recruitment shortly in this multicentric international study. Study sponsor: KolGOTrg Funding: Applied |
http://www.kolgotrg.org/hotroc/ | Study PI: Rahul Roy Chowdhury PI CNCI: Asima Mukhopadhyay PI SGCCRI: Rahul Roy Chowdhury Study coordinator: Mou Dasgupta Contact: kolgotrg@gmail.com |
Developmental Phase for the clinical trial. |
Ovary | NuGenA (Nurse-led Genetic counseling in improving Awareness and implementation of screening services for hereditary women’s cancer in India) |
KOLGO-PROVAR-004 | KolGOTrg has started recruitment in this multicentric international observational/implementation research study. Study sponsor: KolGOTrg Funding: OVARCOME USA Patient Information Sheet for Indian centres: (Download in English) (Download in Bengali) (Download in Hindi) |
http://www.kolgotrg.org/nugena/ | Study PI: Asima Mukhopadhyay PI CNCI: Asima Mukhopadhyay Dona Chakraborty PI SGCCRI: Rahul Roy Chowdhury Study coordinator: Dona Chakraborty Contact: kolgotrg@gmail.com |
Recruiting |
Ovary | SOCQER-IND (Surgery in Ovarian Cancer-Quality of Life Evaluation Research in India) |
- | KolGOTrg has been recruiting patients from India(TMC,Kolkata and CNCI, Kolkata) in this observational study on Quality of Life since 2016. | http://www.kolgotrg.org/socqer-ind/ | Country PI (India): Asima Mukhopadhyay PI CNCI: Asima Mukhopadhyay PI SGCCRI: Rahul Roy Chowdhury PI TMC: Shrikant Atreya Study coordinator India: Supriya Mondal Dona Chakraborty Contact: kolgotrg@gmail.com |
Recruiting |
Ovary | HEPTROC (Health Economic evaluation of Primary Treatment of Ovarian Cancer) |
- | KolGOTrg has been recruiting patients from India(TMC,Kolkata and CNCI, Kolkata) in this observational study on economic evaluation since 2016 | http://www.kolgotrg.org/heptroc/ | Study PI (India): Asima Mukhopadhyay PI CNCI: Asima Mukhopadhyay PI SGCCRI: Rahul Roy Chowdhury PI TMC: Asima Mukhopadhyay Study coordinator India: Aparajita Bhattacharya Contact: kolgotrg@gmail.com |
Recruiting |
Ovary | BIODIVARSITY (BRCAness In Breast and Ovarian Cancer: Impact of Diverse Arsenic Exposure in India in causaTion and PrevenTion strategy) |
KOLGO-PROVAR-005 | KolGOTrg will be starting recruitment shortly in this multicentric observational study. Study sponsor: KolGOTrg Funding: Applied |
http://www.kolgotrg.org/biodivarsity/ | Study PI: Asima Mukhopadhyay PI CNCI: Asima Mukhopadhyay Ranajit Mandal PI SGCCRI: Rahul Roy Chowdhury Study coordinator: Dona Chakraborty Contact: kolgotrg@gmail.com |
Concept development phase |
Cervix | PRECERCA (PREvention of CERvical CAncer: Implementing a point of care HPV testing strategy for cervical cancer screening amongst tea garden workers) | CTRI/2022/10/046796 | KOLGO TRG has
started conducting HPV screening, testing and relevant treatment over various Tea gardens of North Bengal. Study Sponsors and Collaborators: Cepheid, Manisha Nandi Foundation, Suraksha Diagnostics, CNCI Kolkata, Rotary, Newcastle University |
## | Study PI: Asima Mukhopadhyay Study Coordinator: Rama Gupta Daity Bhattacharjee Contact: research@kolgotrg.org |
Recruiting |